[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"ResMed\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":300},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,13,0,[8,40,65,88,112,133,153,172,196,215,234,257,278],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":4},"100618825","circadian-rhythm-monitoring-study-100618825",false,"NCT07336654","Circadian Rhythm Monitoring Study","Evaluation of a Novel Wearable Device for Circadian Rhythm Monitoring in Healthy, OSA, and Insomnia Participants","Inclusion Criteria:\n\n* Adults ≥18 years at screening.\n* Able and willing to provide written informed consent.\n* Belonging to one of three strata: (a) healthy controls without diagnosed sleep disorder, (b) patients with physician-diagnosed OSA, or (c) patients with physician-diagnosed insomnia (based on DSM-5\u002FAASM criteria and ISI ≥15)\n* Capable of using a smartphone for app-based data syncing.\n* Willing to comply with study visits, wearable use, and saliva sampling.\n\nExclusion Criteria:\n\n* • Dermatologic conditions preventing wearable use.\n\n  * Significant psychiatric or neurologic illness that may impair compliance.\n  * Shift work or trans-meridian travel within 2 weeks prior.\n  * Currently pregnant\n  * Use of medications known to significantly alter circadian rhythm (e.g., exogenous melatonin, beta-blockers).",true,"ALL","18 Years",{"count":20,"type":21},30,"ESTIMATED","INTERVENTIONAL",[24],"NA","This will be a single-center, prospective observational study designed to evaluate the feasibility and accuracy of a new wearable device for non-invasive continuous monitoring of physiological signals to derive circadian rhythm. Melatonin sampling will be included for comparison against wearable-derived measures",[27],"Circadian Rhythm","NOT_YET_RECRUITING","2026-05-17",{"date":31,"type":32},"2026-05-19","ACTUAL",{"date":34,"type":21},"2026-07",{"date":36,"type":21},"2026-12",{"name":38,"class":39},"ResMed","INDUSTRY",{"id":41,"slug":42,"hasResults":11,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":4,"eligibilityCriteria":46,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":47,"targetDuration":4,"studyType":22,"phases":49,"briefSummary":50,"conditions":51,"keywords":54,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":58,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},"100593863","asv-therapy-for-insomnia-100593863","NCT07011966","ASV Therapy for Insomnia","Evaluation of Adaptive Servo Ventilation Therapy for Insomnia Treatment Among Patients With Primary Insomnia","Inclusion Criteria:\n\n* ≥ 18 years old\n* Complaint of insomnia when presenting at clinic\n* Diagnosis of moderate to severe insomnia through the Insomnia Severity Index (ISI) with a score ≥ 15\n* Meet diagnostic criteria of Insomnia Disorder (per American Academy of Sleep Medicine)\n* Naïve to treatment for sleep-disordered breathing (SDB), including CPAP, APAP, ASV; mandibular repositioning devices (MRDs), and any other nasal or oral therapy with a primary indication of treating SDB\n* Owns a smartphone and is able to install an application for HSAT data syncing.\n* Able to fully understand study information in English and sign informed consent\n\nExclusion Criteria:\n\n* Primary complaint of sleep-disordered breathing or issues with apneas during sleep or excessive daytime sleepiness\n* Pregnant or planning to be pregnant\n* Any prior diagnosis of severe respiratory disorder or severe sleep disorder such as restless leg syndrome (RLS), idiopathic hypersomnia, or narcolepsy\n* High risk for moderate to severe OSA based on STOP-BANG score.\n* BMI \\> 40 kg\u002Fm2\n* Anticipated changes to start or stop sedative or psychotropic medications during the course of the trial.\n* Medical history of congestive heart failure (CHF) or other potentially unstable cardiac disease as well as chronic lung diseases or other debilitating medical conditions that manifest as more prominent in the patient's health compared to their sleep complaints.\n* Daily use of opiate medications\n* Known contraindications to PAP therapy as listed in the indication for use (i.e. heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤45%) and moderate to severe predominant central sleep apnea).\n* Inability to pre-emptively comply with study procedures\n* Patients who wish to continue using sleeping pills\u002Fhypnotics during the study\n* Patients with conditions affecting the rotation of the condyle in the temporo-mandibular joint.",{"count":48,"type":21},25,[24],"This will be a single center, prospective study designed to evaluate the effect of adaptive servo ventilation therapy on insomnia severity among patients with moderate to severe chronic insomnia.",[52,53],"Insomnia","Insomnia (Moderate)",[52,55,56],"ASV","PAP","RECRUITING",{"date":31,"type":32},{"date":60,"type":32},"2026-03-01",{"date":62,"type":21},"2027-02",{"name":38,"class":39},1,{"id":66,"slug":67,"hasResults":11,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":71,"eligibilityCriteria":72,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":73,"targetDuration":4,"studyType":75,"phases":4,"briefSummary":76,"conditions":77,"keywords":79,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":82,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":64},"100587593","data-collection-study-to-review-novel-methods-for-diagnosing-obstructive-sleep-apnea-100587593","NCT06930404","Data Collection Study to Review Novel Methods for Diagnosing Obstructive Sleep Apnea","Innovation and Growth Network for Insightful Trends and Evaluation - Data Collection Study","Ignite","Inclusion Criteria:\n\nAdults aged \\>= 18 Ability to read and comprehend English\n\nExclusion Criteria:\n\n* Previous diagnosis of OSA\n* Respiratory diseases (such COPD, lung cancer, fibrosis of the lungs, lung injury)\n* Subjects who are or may be pregnant, breastfeeding or within 6 weeks postpartum (which may impact HRV temporarily)\n* Subjects with a pacemaker",{"count":74,"type":21},800,"OBSERVATIONAL","This study will collect data on a range of signals such as facial scans, videos (including speaking, blinking and swallowing) and heart rate variability to assess whether any of these measures are useful for diagnosing obstructive sleep apnea",[78],"Obstructive Sleep Apnea (OSA)",[80,81],"diagnosis","screening",{"date":31,"type":32},{"date":84,"type":32},"2025-09-15",{"date":86,"type":21},"2027-02-15",{"name":38,"class":39},{"id":89,"slug":90,"hasResults":11,"nctId":91,"briefTitle":92,"officialTitle":93,"acronym":94,"eligibilityCriteria":95,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":96,"targetDuration":4,"studyType":22,"phases":98,"briefSummary":100,"conditions":101,"keywords":102,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":104,"lastUpdatePostDateStruct":105,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":4},"100636332","phase-4-informing-patients-with-oximetry-data-to-improve-mad-engagement-100636332","NCT07564310","INFORMing Patients With Oximetry Data to Improve MAD Engagement","INFORMing Patients With Oximetry Data to Improve Mandibular Advancment Device (MAD) Engagement","INFORM","Inclusion Criteria:\n\n* Participants willing to give written informed consent; Participants who can read and comprehend English; ≥ 18 years of age; Participants who have mild-to-moderate OSA, or severe OSA where CPAP has failed, is not tolerated, or is refused; Participants who can participate in the study for up to 4 weeks; Participants who own and can use a smartphone that is compatible with the study app; Participants who have the cognitive ability to follow the study instructions and procedures; Participants who have undergone a panoramic X-ray and are deemed suitable for MRD use\n\nExclusion Criteria:\n\n* Participants who are pregnant or may be pregnant; Participants who have a major psychiatric disorder that, in the investigator's opinion, could interfere with participation; Participants who have severe insomnia, for example usually sleeping less than about four hours per night; Participants believed to be unsuitable for the study for safety or other medical reasons by the investigator; Participants who are currently enrolled in another medical clinical study; Participants who have central sleep apnoea; Participants who have severe respiratory disorders other than OSA; Participants who have dental contraindications to using an oral appliance, such as loose teeth or advanced periodontal (gum) disease; Participants who have a completely edentulous lower arch (no lower teeth) unless a complete denture that is mechanically retained (for example, by implants) is present; Participants who have a completely edentulous upper arch (no upper teeth) unless a complete upper denture is present; Participants who have short teeth and\u002For insufficient undercuts to retain the device securely",{"count":97,"type":21},120,[99],"PHASE4","Obstructive sleep apnea (OSA) is common and associated with impaired daytime functioning, reduced quality of life and increased cardiovascular, metabolic and perioperative risk.\n\nMandibular advancement devices (MADs) are a guideline-supported, non-invasive alternative to CPAP for patients with mild to moderate OSA and for those with severe OSA who refuse or cannot tolerate CPAP.\n\nMAD therapy relies heavily on patient engagement and sustained use over time. However, in usual care, patients typically have limited access to objective information about their treatment response. Titration is often based on intermittent assessments and subjective symptom reporting, with little real-time feedback to patients on treatment effectiveness.\n\nThis lack of visibility may limit patient understanding of their condition, reduce engagement with therapy, and delay optimisation of treatment.\n\nAdvances in nocturnal oximetry now enable multi-night, home-based assessment of oxygen desaturation and related metrics. The myNarval CC solution provides patients, alongside clinicians, with access to objective oximetry data during MAD therapy. By increasing patient awareness of treatment response, this approach has the potential to enhance engagement, support adherence, and improve the overall treatment experience.\n\nThe purpose of this study is to evaluate whether access to oximetry data through the myNarval CC solution improves patient-reported experience measures (PREMs) compared with standard care in patients treated with MADs for OSA.",[78],[103],"mandibular advancement device MAD","2026-04-26",{"date":106,"type":32},"2026-05-04",{"date":108,"type":21},"2026-06-01",{"date":110,"type":21},"2027-05-01",{"name":38,"class":39},{"id":113,"slug":114,"hasResults":11,"nctId":115,"briefTitle":116,"officialTitle":116,"acronym":4,"eligibilityCriteria":117,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":118,"enrollmentInfo":119,"targetDuration":4,"studyType":22,"phases":121,"briefSummary":122,"conditions":123,"keywords":4,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":125,"lastUpdatePostDateStruct":126,"startDateStruct":128,"completionDateStruct":130,"leadSponsor":132,"locationsCount":64},"100459424","post-market-clinical-follow-up-of-resmed-mask-systems-100459424","NCT05262439","Post Market Clinical Follow up of ResMed Mask Systems","Inclusion Criteria:\n\n* Participants willing to give written informed consent\n* Participants who can read and comprehend English\n* Participants who ≥ 18 years of age\n* Participants being treated for OSA for ≥ 6 months\n* Participants currently using a suitable mask system\n* Participants currently using CPAP device compatible with AirView, or with download capacity from CPAP machine from data cards\n\nExclusion Criteria:\n\n* Participants using Bilevel flow generators\n* Participants who are or may be pregnant\n* Participants with a pre-existing lung disease\u002F condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (\\\u003C 2years) case of pneumonia or lung infection; lung injury.\n* Participants believed to be unsuitable for inclusion by the researcher\n* Participants who or whose bed partner has implantable metallic implants in the head, neck and chest region affected by magnetic fields (Non-ferrous implants may be acceptable) (for masks with magnetic clips only)","100 Years",{"count":120,"type":21},500,[24],"Post Market follow up study to systematically and proactively collect supplementary real world data to confirm the usability and performance of the new generation mask systems. .",[124],"Obstructive Sleep Apnea","2026-04-23",{"date":127,"type":32},"2026-04-29",{"date":129,"type":32},"2022-05-26",{"date":131,"type":21},"2027-06",{"name":38,"class":39},{"id":134,"slug":135,"hasResults":11,"nctId":136,"briefTitle":137,"officialTitle":138,"acronym":4,"eligibilityCriteria":139,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":140,"enrollmentInfo":141,"targetDuration":4,"studyType":22,"phases":142,"briefSummary":143,"conditions":144,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":145,"lastUpdatePostDateStruct":146,"startDateStruct":148,"completionDateStruct":150,"leadSponsor":152,"locationsCount":4},"100559290","pap-systems-external-clinical-studies-ecs-100559290","NCT06562205","PAP Systems External Clinical Studies (ECS)","External Evaluation of PAP Systems: Comparison of PAP Flow Generators Machines, Mask Systems and Tubing","Inclusion Criteria:\n\n* Participants willing to give written informed consent\n* Participants who ≥ 18 years of age\n* Participants being treated for OSA for ≥ 3 months\n* Participants currently using a suitable PAP system(s)\n* Participants who can trial the PAP systems for up to 7 nights each\n\nAdditional criteria for remote studies:\n\n* Participants currently using PAP device compatible with AirView, or with download capacity from PAP machine from data cards\n* Participants who have access to video call equipment\n\nExclusion Criteria:\n\n* Participants using Bilevel flow generators\n* Participants who are or may be pregnant\n* Participants with a preexisting lung disease\u002F condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (\\\u003C 2years) case of pneumonia or lung infection; lung injury.\n* Participants believed to be unsuitable for inclusion by the researcher\n* Participants who or whose bed partner has implantable medical devices which may contraindicate against masks with magnetic clips (exclusion criteria for study masks with magnetic clips only)\n* Participants who are currently enrolled in other clinical studies","130 Years",{"count":20,"type":21},[24],"This is a pre-market study for ongoing product development aiming to explore the usability and performance of the study PAP systems.",[124],"2026-04-22",{"date":147,"type":32},"2026-04-24",{"date":149,"type":21},"2028-08-01",{"date":151,"type":21},"2028-10-29",{"name":38,"class":39},{"id":154,"slug":155,"hasResults":11,"nctId":156,"briefTitle":157,"officialTitle":157,"acronym":4,"eligibilityCriteria":158,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":159,"targetDuration":4,"studyType":75,"phases":4,"briefSummary":161,"conditions":162,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":163,"lastUpdatePostDateStruct":164,"startDateStruct":166,"completionDateStruct":168,"leadSponsor":170,"locationsCount":171},"100630277","exploration-of-current-and-new-technologies-for-accuracy-of-diagnosing-osa-100630277","NCT07485582","Exploration of Current and New Technologies for Accuracy of Diagnosing OSA","Inclusion Criteria:\n\n* Participant is 18 years of age or older\n* Participant is willing to provide informed consent\n* Participant is willing to participate in all study related procedures\n\nExclusion Criteria:\n\n* Unable to cease PAP therapy during PSG (if currently using)\n* Requires use of oxygen therapy during sleep\n* Diagnosis of untreated clinically relevant sleep disorder (other than SDB, e.g. severe insomnia)\n* Who are or may be pregnant\n* Participants are unsuitable to participate in the study in the opinion of the investigator\n* Participant has a permanent pacemaker, sustained non-sinus cardiac arrhythmias, and\u002For takes alpha blocker or short acting nitrate medication.\n* Shift workers who worked an overnight shift in the past 3 days\n* Participant who are contraindicated to use the NightOwl sensor",{"count":160,"type":21},90,"Resmed is the manufacturer of medical devices which screen, diagnose, treat and monitor people with sleeping and respiratory disorders, such as obstructive sleep apnea (OSA).\n\nFrom time to time, for regulatory, quality, and marketing purposes, there may be a need to test the various products performance against PSG (gold standard technology), and other products.\n\nThe purpose of this study is:\n\n1. Products performance against PSG\n2. comparison against other products, and\n3. Assessments of potential new technologies",[124],"2026-03-16",{"date":165,"type":32},"2026-03-20",{"date":167,"type":21},"2026-04",{"date":169,"type":21},"2026-10",{"name":38,"class":39},7,{"id":173,"slug":174,"hasResults":11,"nctId":175,"briefTitle":176,"officialTitle":177,"acronym":4,"eligibilityCriteria":178,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":179,"targetDuration":4,"studyType":22,"phases":181,"briefSummary":182,"conditions":183,"keywords":185,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":188,"lastUpdatePostDateStruct":189,"startDateStruct":191,"completionDateStruct":193,"leadSponsor":195,"locationsCount":4},"100625246","evaluation-of-a-wearable-pap-device-in-a-tethered-configuration-for-the-treatment-of-obstructive-sleep-apnoea-100625246","NCT07420140","Evaluation of a Wearable PAP Device in a Tethered Configuration for the Treatment of Obstructive Sleep Apnoea.","Evaluation of a Wearable PAP Device in a Tethered Configuration for the Treatment of Obstructive Sleep Apnea.","Inclusion Criteria: • Participants willing to give written informed consent\n\n* Participants who ≥ 18 years of age\n* Participants who can trial the APL mask system for up to 7 nights\n* Participants willing and able to complete the specified tasks\n* Participants being treated for Obstructive Sleep Apnea (OSA) for ≥ 3 months\\*\n* Participants on APAP therapy\\*\n* Participants currently using a Resmed AirFit N20 Medium mask\\*\n* Participants who are employees of Resmed\\^\n\n  * Only applicable to participants with OSA \\^ Only applicable to internal participants\n\nExclusion Criteria:\n\n* Participants using Bilevel flow generators\n\n  * Participants who are or may be pregnant\n  * Participants with a preexisting lung disease\u002F condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (\\\u003C 2years) case of pneumonia or lung infection; lung injury.\n  * Participants (or participants bed partners) with active medical implants that interact with magnets (i.e., pacemakers, implantable cardioverter defibrillators (ICD), neurostimulators, cerebrospinal fluid (CSF) shunts, insulin\u002Finfusion pumps).\n  * Participants (or participants bed partners) with metallic implants\u002Fobjects containing ferromagnetic material (i.e., aneurysm clips\u002Fflow disruption devices, embolic coils, stents, valves, electrodes, implants to restore hearing or balance with implanted magnets, ocular implants, metallic splinters in the eye)\n  * Participants who are currently enrolled in other clinical studies\n  * Participants believed to be unsuitable\\* for inclusion by the researcherꝉ",{"count":180,"type":21},15,[24],"Each participant will wear a wearable PAP device, tethered to a released PAP device for up to 7 nights. Objectives include collecting and evaluating participants feedback on seal, comfort and usability of the wearable PAP device.",[184],"OSA - Obstructive Sleep Apnea",[186,187],"OSA","CPAP","2026-02-12",{"date":190,"type":32},"2026-02-19",{"date":192,"type":21},"2026-03",{"date":194,"type":21},"2026-06",{"name":38,"class":39},{"id":197,"slug":198,"hasResults":11,"nctId":199,"briefTitle":200,"officialTitle":201,"acronym":202,"eligibilityCriteria":203,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":204,"targetDuration":4,"studyType":22,"phases":205,"briefSummary":206,"conditions":207,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":208,"lastUpdatePostDateStruct":209,"startDateStruct":210,"completionDateStruct":212,"leadSponsor":214,"locationsCount":64},"100623763","study-of-min-max-apap-recommender-tool-100623763","NCT07400861","Study of Min-Max APAP Recommender Tool","Trial of a New Software Tool for Personalized Minimum and Maximum Pressure Recommendations in New CPAP Users With OSA","SMART","Inclusion Criteria:\n\n* Patients willing to give written informed consent\n* Patients who can read and comprehend English\n* Patients who are ≥ 18 years of age\n* Patients newly diagnosed with OSA (AHI ≥ 5) and indicated for CPAP therapy.\n\nExclusion Criteria:\n\n* Patients who have previously used PAP therapy\n* Patients who require a bilevel device\n* Patients who are or may be pregnant\n* Patients with a preexisting lung disease\u002F condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (\\\u003C 2years) case of pneumonia or lung infection; lung injury\n* Patients whose physician has dictated specific therapy settings (e.g. fixed pressure CPAP, or specific AutoSet minimum and\u002F or maximum settings)",{"count":160,"type":21},[24],"Pressure Match (The APAP Min-Max tool) is a software-based clinical decision-support tool, developed using a causal-inference modelling approach based on data from thousands of OSA patients. The model takes as inputs from patient variables (e.g., baseline AHI, gender, weight\u002FBMI, mask interface type), and outputs recommended AutoSet minimum and maximum pressure settings (cmH₂O) tailored for that patient phenotype.\n\nThe intended clinical role of the Pressure Match tool is to assist the clinician's choice of AutoSet pressure range when initiating CPAP therapy, with the goal of reducing clinician time\u002Feffort in manual titration and follow-up adjustments without compromising safety, efficacy or patient satisfaction.\n\nThe purpose of this trial is to test Pressure Match in a clinical trial setting, to demonstrate non-inferiority against standard APAP settings.",[78],"2026-02-09",{"date":188,"type":32},{"date":211,"type":21},"2026-04-01",{"date":213,"type":21},"2027-03-01",{"name":38,"class":39},{"id":216,"slug":217,"hasResults":11,"nctId":218,"briefTitle":219,"officialTitle":219,"acronym":4,"eligibilityCriteria":220,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":221,"targetDuration":4,"studyType":22,"phases":223,"briefSummary":224,"conditions":225,"keywords":4,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":226,"lastUpdatePostDateStruct":227,"startDateStruct":229,"completionDateStruct":231,"leadSponsor":233,"locationsCount":64},"100575232","evaluation-of-a-novel-auto-adjusting-positive-airway-pressure-algorithm-for-the-treatment-of-obstructive-sleep-apnea-clinical-study-100575232","NCT06769607","Evaluation of a Novel Auto-Adjusting Positive Airway Pressure Algorithm for the Treatment of Obstructive Sleep Apnea Clinical Study","Inclusion Criteria:\n\n* Participants willing to give written informed consent.\n* Participants who can read and comprehend English.\n* Participants who ≥ 18 years of age\n* Participants who have been using a ResMed AirSense 10 or 11 device.\n* Participants currently using AutoSet (APAP) mode.\n* Participants being established on PAP therapy for the treatment of OSA for approximately \\>3 months.\n* Participants who can participate in the study for up to 8 weeks.\n\nExclusion Criteria:\n\n* Participants using Bilevel flow generators.\n* Participants using CPAP, AutoSet for Her\n* Participants who are or may be pregnant.\n* Participants with a preexisting lung disease\u002F condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (\\\u003C 2years) case of pneumonia or lung infection; lung injury.\n* Participants believed to be unsuitable for inclusion by the researcher.\n* Participants who are currently enrolled in other medical clinical studies",{"count":222,"type":21},80,[24],"This study aims to assess the effectiveness of an investigational algorithm in the treatment of obstructive sleep apnea.",[124],"2025-11-24",{"date":228,"type":32},"2025-12-02",{"date":230,"type":32},"2025-04-10",{"date":232,"type":21},"2025-12",{"name":38,"class":39},{"id":235,"slug":236,"hasResults":11,"nctId":237,"briefTitle":238,"officialTitle":239,"acronym":4,"eligibilityCriteria":240,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":241,"targetDuration":4,"studyType":75,"phases":4,"briefSummary":243,"conditions":244,"keywords":246,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":249,"lastUpdatePostDateStruct":250,"startDateStruct":252,"completionDateStruct":254,"leadSponsor":256,"locationsCount":4},"100600568","nyx3-data-collection-study-100600568","NCT07099183","Nyx3 Data Collection Study","Nyx3 Eye Mask Physiological Data Collection Study","Inclusion Criteria:\n\n* Participants willing to give written informed consent\n* Participants who ≥ 18 years of age\n* Participants who can trial the eye mask overnight\n\nExclusion Criteria:\n\n* Participants with active medical implants that interact with magnets (i.e., pacemakers, implantable cardioverter defibrillators (ICD), neurostimulators, cerebrospinal fluid (CSF) shunts, insulin\u002Finfusion pumps).\n* Participants with metallic implants\u002Fobjects containing ferromagnetic material (i.e., aneurysm clips\u002Fflow disruption devices, embolic coils, stents, valves, electrodes, implants to restore hearing or balance with implanted magnets, ocular implants, metallic splinters in the eye)\n* Participants who are or may be pregnant\n* Participants who are currently enrolled in other clinical studies",{"count":242,"type":21},60,"Each participant will wear the Nyx3 eye mask and Hypnodyne headband for 1 night at-home. Objectives include collecting and evaluating data quality from the Nyx3 eye mask, and exploring the impact of its paced breathing feature on sleep onset latency.",[245],"Sleep Staging",[247,248],"EEG","Sleep Eye Mask","2025-07-25",{"date":251,"type":32},"2025-08-01",{"date":253,"type":21},"2025-07-30",{"date":255,"type":21},"2025-10-01",{"name":38,"class":39},{"id":258,"slug":259,"hasResults":11,"nctId":260,"briefTitle":261,"officialTitle":261,"acronym":262,"eligibilityCriteria":263,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":264,"enrollmentInfo":265,"targetDuration":266,"studyType":75,"phases":4,"briefSummary":267,"conditions":268,"keywords":4,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":269,"lastUpdatePostDateStruct":270,"startDateStruct":272,"completionDateStruct":274,"leadSponsor":276,"locationsCount":277},"100356731","registry-study-on-prescription-patient-pathways-therapy-efficacy-and-usage-of-mandibular-advancement-devices-in-obstructive-sleep-apnea---patt-osa-registry-100356731","NCT03924817","Registry Study on Prescription, Patient Pathways, Therapy Efficacy and Usage of Mandibular Advancement Devices in Obstructive Sleep Apnea - PATT-OSA Registry","PATT-OSA","Inclusion Criteria:\n\n* Prescription of any mandibular advancement device\n* Age ≥ 18 years\n* Ability to understand the study information and information on usage of personal data\n* Signed and dated informed consent\n\nExclusion Criteria:\n\n* Patients with central sleep apnea (central AI \\> 5\u002Fhour)\n* Patients with loose teeth and severe parodontitis\n* Patients with completely missing teeth or removable tooth replacement, or with a teeth health insufficient to retain an MAD Patients with missing molars Patients with maximum protrusion of less than 5mm","99 Years",{"count":120,"type":21},"3 Months","During sleep, the muscle tonus in the oropharyngeal space is lost, the tongue might fall back andthe volume of the pharynx decreases. Air cannot pass through as it would in the awake state and thus airflow limitations occur. The person asleep might compensate the flow limitation by breathing faster, which causes the soft tissue to vibrate (= snoring). Further narrowing of the airways can lead to obstructive apneas (complete airway collapse and stopping of airflow). First line therapy for obstructive sleep apnea (OSA) is positive airway pressure (PAP) that keeps the airways open with a pneumatic splint. Since PAP involves wearing a facial mask that applies air pressure into the airways, some patients cannot tolerate this therapy. These patients might be candidates for an alternative treatment approach with a mandibular advancement device (MAD).",[124],"2024-10-25",{"date":271,"type":32},"2024-10-29",{"date":273,"type":32},"2024-02-01",{"date":275,"type":21},"2025-06-30",{"name":38,"class":39},4,{"id":279,"slug":280,"hasResults":11,"nctId":281,"briefTitle":282,"officialTitle":283,"acronym":284,"eligibilityCriteria":285,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":286,"enrollmentInfo":287,"targetDuration":4,"studyType":75,"phases":4,"briefSummary":289,"conditions":290,"keywords":4,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":291,"lastUpdatePostDateStruct":292,"startDateStruct":294,"completionDateStruct":296,"leadSponsor":298,"locationsCount":299},"100472739","long-term-benefits-of-cpap-or-mad-treatment-on-the-sleep-of-osas-patients-100472739","NCT05435794","Long-term Benefits of CPAP or MAD Treatment on the Sleep of OSAS Patients","Long-term Benefits of Continuous Positive Pressure Therapy or Mandibular Advancement Devise on the Sleep of Patients With Obstructive Sleep Apnea","REMAP","Inclusion Criteria:\n\n* Patient already included in the SunSAS study (No. ID\u002FRCB: 2021-A01827-34) or Patient who has undergone polygraphy or polysomnography eligible for treatment with CPAP or MAD in the context of OSA.\n* Patient with a sleep test performed with the Sunrise device\n* Men or Women from 18 to 80 years old\n* Patient with OSAS eligible for CPAP or MAD therapy\n* Affiliated patient or beneficiary of a social security scheme\n* Signed informed consent\n\nExclusion Criteria:\n\n* Patient previously treated for OSAS by CPAP or MAD during the last five years\n* Patient with COPD or other respiratory diseases.\n* Patient with contraindications to PPC or MAD therapy\n* Patient with unstable heart disease or New York Heart Association class III or IV heart failure\n* Patient unable to complete the study","80 Years",{"count":288,"type":21},400,"The REMAP study aims to follow a cohort of 400 patients in around ten sleep centers in France and to collect clinical routine data. The objectives of this study are to investigate the effects of one-year management of OSA by CPAP or MAD on sleep architecture defined by objective macro and micro sleep architecture parameters using a sleep test device. sleep connected at home, to assess the quality of sleep and the quality of life reported by patients. The study will also allow us to define predictive factors for improving sleep quality during OSA treatment.",[186],"2024-05-17",{"date":293,"type":32},"2024-05-21",{"date":295,"type":32},"2022-07-15",{"date":297,"type":21},"2026-10-15",{"name":38,"class":39},9,""]